These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 19817721

  • 1. Diabetic macular oedema and visual loss: relationship to location, severity and duration.
    Gardner TW, Larsen M, Girach A, Zhi X, Protein Kinase C Diabetic Retinopathy Study (PKC-DRS2) Study Group.
    Acta Ophthalmol; 2009 Nov; 87(7):709-13. PubMed ID: 19817721
    [Abstract] [Full Text] [Related]

  • 2. Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy.
    PKC-DRS2 GroupBeetham Eye Institute, Joslin Diabetes Center, 1 Joslin Place, Boston, MA 02215, USA. LPAiello@Joslin.Harvard.edu, Aiello LP, Davis MD, Girach A, Kles KA, Milton RC, Sheetz MJ, Vignati L, Zhi XE.
    Ophthalmology; 2006 Dec; 113(12):2221-30. PubMed ID: 16989901
    [Abstract] [Full Text] [Related]

  • 3. Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study 2.
    Aiello LP, Vignati L, Sheetz MJ, Zhi X, Girach A, Davis MD, Wolka AM, Shahri N, Milton RC, PKC-DRS and PKC-DRS2 Study Groups.
    Retina; 2011 Nov; 31(10):2084-94. PubMed ID: 21862954
    [Abstract] [Full Text] [Related]

  • 4. Effect of ruboxistaurin on the visual acuity decline associated with long-standing diabetic macular edema.
    Davis MD, Sheetz MJ, Aiello LP, Milton RC, Danis RP, Zhi X, Girach A, Jimenez MC, Vignati L, PKC-DRS2 Study Group.
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):1-4. PubMed ID: 18708615
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of ruboxistaurin (RBX) On visual acuity decline over a 6-year period with cessation and reinstitution of therapy: results of an open-label extension of the Protein Kinase C Diabetic Retinopathy Study 2 (PKC-DRS2).
    Sheetz MJ, Aiello LP, Shahri N, Davis MD, Kles KA, Danis RP, Mbdv Study Group.
    Retina; 2011 Jun; 31(6):1053-9. PubMed ID: 21386766
    [Abstract] [Full Text] [Related]

  • 7. Uveitic macular oedema: correlation between optical coherence tomography patterns with visual acuity and fluorescein angiography.
    Tran TH, de Smet MD, Bodaghi B, Fardeau C, Cassoux N, Lehoang P.
    Br J Ophthalmol; 2008 Jul; 92(7):922-7. PubMed ID: 18577643
    [Abstract] [Full Text] [Related]

  • 8. Effect of ruboxistaurin on the visual acuity decline associated with long-standing diabetic macular edema.
    Sahu AK, Majji AB.
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6890; author reply 6890-1. PubMed ID: 21123772
    [No Abstract] [Full Text] [Related]

  • 9. The predictive value of optical coherence tomography after grid laser photocoagulation for diffuse diabetic macular oedema.
    Soliman W, Sander B, Soliman KA, Yehya S, Rahamn MS, Larsen M.
    Acta Ophthalmol; 2008 May; 86(3):284-91. PubMed ID: 18005220
    [Abstract] [Full Text] [Related]

  • 10. Sustained moderate visual loss as a predictive end point for visual loss in non-proliferative diabetic retinopathy.
    Girach A, Aiello LP, Milton RC, Davis MD, Danis RP, Zhi X, Sheetz MJ, Vignati L, PKC-DRS2 Study Group.
    Eye (Lond); 2009 Jan; 23(1):209-14. PubMed ID: 18989348
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Optical coherence tomographic patterns in diabetic macular oedema: prediction of visual outcome after focal laser photocoagulation.
    Kim NR, Kim YJ, Chin HS, Moon YS.
    Br J Ophthalmol; 2009 Jul; 93(7):901-5. PubMed ID: 19254904
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.
    Vujosevic S, Bottega E, Casciano M, Pilotto E, Convento E, Midena E.
    Retina; 2010 Jun; 30(6):908-16. PubMed ID: 20168272
    [Abstract] [Full Text] [Related]

  • 17. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography.
    Kim SJ, Equi R, Bressler NM.
    Ophthalmology; 2007 May; 114(5):881-9. PubMed ID: 17275910
    [Abstract] [Full Text] [Related]

  • 18. Quantifying alterations of macular thickness before and after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision.
    Shimura M, Yasuda K, Nakazawa T, Kano T, Ohta S, Tamai M.
    Ophthalmology; 2003 Dec; 110(12):2386-94. PubMed ID: 14644723
    [Abstract] [Full Text] [Related]

  • 19. Short-term effects of intravitreal triamcinolone on retinal vascular leakage and trunk vessel diameters in diabetic macular oedema.
    Vinten M, Larsen M, Lund-Andersen H, Sander B, La Cour M.
    Acta Ophthalmol Scand; 2007 Feb; 85(1):21-6. PubMed ID: 17244205
    [Abstract] [Full Text] [Related]

  • 20. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
    Dusová J, Studnicka J, Rencová E, Korda V, Hejcmanová D.
    Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.